| Systematic (IUPAC) name | |
|---|---|
| 5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | Not established[1] |
| Legal status | ? |
| Routes | oral[1] |
| Identifiers | |
| CAS number | 524-81-2 |
| ATC code | R06AX15 |
| PubChem | CID 22530 |
| ChemSpider | 21129 |
| UNII | 9SUK9B7XVY |
| KEGG | D08161 |
| Synonyms | 9-Benzyl-2-methyl-2,3,4,9-tetrahydro-1H-β-carboline, Incidal, Omeril, diazolin, Fabahistin, mebhydrolin napadisylate, mebhydroline 1,5-naphthalenedisulfonate[3] |
| Chemical data | |
| Formula | C19H20N2[4] |
| Mol. mass | 276.376 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Mebhydrolin (INN) or mebhydroline is an antihistamine. It is not available in the United States, but it is in various other countries. It is also called Bexidal (BD) and Diazolin (RU). It is used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allergic dermatosis.
Mebhydrolin has been shown to enhance the performance-deficit effects of alcohol.[5]
|
|||||||||||||||||
| This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)